Number | Ticker | Country | Founded | Industry | Sector | Price | Revenue | EPS (Earning-Per-Share) | Analyst Decision |
---|---|---|---|---|---|---|---|---|---|
1 | United States | 1988 | Biotechnology: Pharmaceutical Preparations | Health Care | $547.74 | $14,085,700,000.00 | $39.43 | Buy | |
2 | United States | 1996 | Biotechnology: Pharmaceutical Preparations | Health Care | $295.22 | $2,994,100,000.00 | $25.10 | Buy | |
3 | Denmark | 1999 | Biotechnology: Pharmaceutical Preparations | Health Care | $20.44 | $3,230,902,140.00 | $18.36 | Buy | |
4 | United States | 1876 | Biotechnology: Pharmaceutical Preparations | Health Care | $779.15 | $49,003,200,000.00 | $12.29 | Strong Buy | |
5 | United States | 2007 | Biotechnology: Pharmaceutical Preparations | Health Care | $35.35 | $37,035,000.00 | $11.45 | Buy | |
6 | United States | 1978 | Biotechnology: Pharmaceutical Preparations | Health Care | $133.19 | $9,816,400,000.00 | $10.12 | Buy | |
7 | United States | 1886 | Biotechnology: Pharmaceutical Preparations | Health Care | $155.55 | $89,331,000,000.00 | $8.98 | Buy | |
8 | Ireland | 2003 | Biotechnology: Pharmaceutical Preparations | Health Care | $109.92 | $4,064,808,000.00 | $7.51 | Strong Buy | |
9 | United States | 1998 | Biotechnology: Pharmaceutical Preparations | Health Care | $49.15 | $1,772,758,000.00 | $7.51 | Buy | |
10 | United States | 2000 | Biotechnology: Pharmaceutical Preparations | Health Care | $82.38 | $63,922,000,000.00 | $6.88 | Buy | |
11 | United States | 1952 | Biotechnology: Pharmaceutical Preparations | Health Care | $159.07 | $9,286,000,000.00 | $5.57 | Buy | |
12 | United States | 1996 | Biotechnology: Pharmaceutical Preparations | Health Care | $80.12 | $1,137,762,000.00 | $4.29 | Buy | |
13 | United States | 1996 | Biotechnology: Pharmaceutical Preparations | Health Care | $57.17 | $2,950,227,000.00 | $2.71 | Buy | |
14 | United States | 2017 | Biotechnology: Pharmaceutical Preparations | Health Care | $32.11 | $744,852,000.00 | $2.62 | Strong Buy | |
15 | United States | 2012 | Biotechnology: Pharmaceutical Preparations | Health Care | $190.78 | $57,367,000,000.00 | $2.34 | Buy | |
16 | Ireland | 1987 | Biotechnology: Pharmaceutical Preparations | Health Care | $29.00 | $1,513,770,000.00 | $2.09 | Buy | |
17 | United States | 1996 | Biotechnology: Pharmaceutical Preparations | Health Care | $18.65 | $203,077,000.00 | $2.08 | Buy | |
18 | United States | 2002 | Biotechnology: Pharmaceutical Preparations | Health Care | $21.45 | $534,645,999.00 | $1.57 | Strong Buy | |
19 | United States | 1993 | Biotechnology: Pharmaceutical Preparations | Health Care | $21.24 | $996,283,000.00 | $1.37 | Buy | |
20 | United States | 2002 | Biotechnology: Pharmaceutical Preparations | Health Care | $30.51 | $664,283,000.00 | $1.25 | Strong Buy | |
21 | United States | 1998 | Biotechnology: Pharmaceutical Preparations | Health Care | $71.34 | $685,446,000.00 | $1.14 | Strong Buy | |
22 | United States | 2014 | Biotechnology: Pharmaceutical Preparations | Health Care | $11.55 | $190,908,000.00 | $0.88 | Strong Buy | |
23 | United States | 2006 | Biotechnology: Pharmaceutical Preparations | Health Care | $50.69 | $207,801,000.00 | $0.86 | Strong Buy | |
24 | United States | 1954 | Biotechnology: Pharmaceutical Preparations | Health Care | $14.73 | $4,427,000,000.00 | $0.75 | Buy | |
25 | United States | 2006 | Biotechnology: Pharmaceutical Preparations | Health Care | $11.59 | $82,553,827.00 | $0.28 | Strong Buy | |
26 | TGTXTG Therapeutics Inc. | United States | 1993 | Biotechnology: Pharmaceutical Preparations | Health Care | $36.29 | $386,386,000.00 | $0.24 | Strong Buy |
27 | United States | 2015 | Biotechnology: Pharmaceutical Preparations | Health Care | $13.41 | $214,713,000.00 | $0.11 | Buy | |
28 | United States | 1991 | Biotechnology: Pharmaceutical Preparations | Health Care | $3.62 | $297,595,000.00 | $0.10 | Buy |
The FinQuota filters have identified what they believe to be the "Best Pharmaceutical Stocks to Buy in July 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.